JPRN-UMIN000011152
Recruiting
未知
Phase II study to evaluate efficacy and safety of retherapy with bendamustine and rituximab regimens in patients with relapsed/refractory indolent B-cell lymphomas and mantle cell lymphomas - B-SRIM Study
B-SRIM Study Group0 sites38 target enrollmentJuly 11, 2013
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- B-SRIM Study Group
- Enrollment
- 38
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Patients who are pregnant or in the location period, and who are not able to, or not willing to prevent conception during the therapeutic period of this clinical study 2\. Patients who have coinciding active cancer 3\. Patients who have psychiatric disorder 4\. Patients who have circulating lymphoma cells \>\= 25,000 /uL in peripheral blood 5\. Patients who have interstitial pneumonia or pulmonary fibrosis 6\. Patients who have central nerve system lymphoma 7\. Patients who have severe allergic reaction to medication 8\. Patients who are considered as inappropriate to register by physician
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
uPBSCT with PTCY for ATadult T-cell leukemia/lymphomaJPRN-jRCTs031200375Fukuda Takahiro24
Active, not recruiting
Phase 1
Study to evaluate efficacy and safety of sunitinib in patients with renal cell carcinoma who have progressed to first-line immunotherapy treatmentmetastatic renal clear cell carcinomaMedDRA version: 19.1Level: LLTClassification code 10038416Term: Renal clear cell carcinomaSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2016-004011-12-ESSOGUG (Spanish Oncology Genitourinary Group)
Not yet recruiting
Phase 2
Phase II Study to evaluate efficacy and safety of Lenalidomide maintenance therapy for multiple myeloma patients under bortezomib treatmentmultiple myelomaJPRN-UMIN000013881ational Defense Medical College29
Recruiting
Phase 2
A phase II study to reveal safety and efficacy of TM5509 in cord blood transplantatioCord Blood TransplantationJPRN-UMIN000018180Tohoku university school of medicine, molecular medicine and therapy, Toshio Miyata21
Not yet recruiting
Phase 2
A phase 2 study to evaluate safety and efficacy of laparoscopic sleeve gastrectomy with duodenojejunal bypass for obesity with diabetes mellitusMorbid obesity with diabetes mellitusJPRN-UMIN000035537Kansai Medical University Hospital33